| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.089 | 0.07 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.08 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.08 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.095 | 0.08 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |